Login / Signup

CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma.

Gennadi TulchinerAndrea BrunnerManuela SchmidingerNina StaudacherJacob J OrmeMartin ThurnherWolfgang HorningerZoran CuligRenate Pichler
Published in: BJU international (2021)
Keyphrases
  • metastatic renal cell carcinoma
  • poor prognosis
  • binding protein
  • long non coding rna